HNF1A and HNF4A mutations cause a similar clinical phenotype of MODY, characterized by progressive beta-cell dysfunction, defects in glucose-stimulated insulin secretion [7,8] and sensitivity to low-dose sulphonylureas [9]. The gene discussed is HNF1A; the disease is MODY.